Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...
Dexcom announced that its G7 continuous glucose monitoring (CGM) system is now available to all Medicare patients with diabetes who meet the eligibility criteria, following the system launch last week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results